Preoperative hemoglobin A1c levels and increased risk of adverse limb events in diabetic patients undergoing infrainguinal lower extremity bypass surgery in the Vascular Quality Initiative.

[1]  R. Mehta,et al.  Long‐term outcomes of patients with diabetes mellitus undergoing percutaneous intervention for popliteal and infrapopliteal peripheral arterial disease , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[2]  T. Wilt,et al.  Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians , 2018, Annals of Internal Medicine.

[3]  D. Dunson,et al.  Effect of A1C and Glucose on Postoperative Mortality in Noncardiac and Cardiac Surgeries , 2018, Diabetes Care.

[4]  Vivien Leung,et al.  Perioperative Management of Patients with Diabetes , 2017, Health services insights.

[5]  H. Verhagen,et al.  Outcomes after first‐time lower extremity revascularization for chronic limb‐threatening ischemia between patients with and without diabetes , 2017, Journal of vascular surgery.

[6]  J. Cigarroa,et al.  Correction to: 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Circulation.

[7]  E. Brilakis,et al.  Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus , 2017, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[8]  D. Lobo,et al.  Systematic review of the impact of HbA1c on outcomes following surgery in patients with diabetes mellitus. , 2016, Clinical nutrition.

[9]  Young Seol Kim,et al.  Peripheral Arterial Disease in Patients with Type 2 Diabetes Mellitus , 2015, Diabetes & metabolism journal.

[10]  E. Armstrong,et al.  Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes. , 2015, World journal of diabetes.

[11]  F. Moll,et al.  Risk Chart for Future Mortality and Ischaemic Events Following Peripheral Bypass Surgery. , 2015, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[12]  R. Naibaho,et al.  Risk factors for lower extremity amputation in patients with diabetic foot ulcers: a hospital-based case–control study , 2015, Diabetic foot & ankle.

[13]  D. Ren,et al.  Perioperative glucose monitoring and treatment of patients undergoing vascular surgery in a community hospital setting. , 2014, AANA journal.

[14]  M. Davies,et al.  Impact of elevated perioperative fasting blood glucose on carotid artery stenting outcomes. , 2014, Annals of vascular surgery.

[15]  G. Reiber,et al.  Improving outcomes for diabetic patients undergoing revascularization for critical limb ischemia: does the quality of outpatient diabetic care matter? , 2014, Annals of vascular surgery.

[16]  E. Amsterdam,et al.  Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty , 2014, Vascular medicine.

[17]  A. Toniato,et al.  Lower extremity arterial reconstruction for critical limb ischemia in diabetes. , 2014, Journal of vascular surgery.

[18]  M. Muller,et al.  Physiology in medicine: peripheral arterial disease. , 2013, Journal of applied physiology.

[19]  S. Nakaji,et al.  The influence of blood glucose on neutrophil function in individuals without diabetes. , 2013, Luminescence : the journal of biological and chemical luminescence.

[20]  A. Jatoi,et al.  Preoperative testing before noncardiac surgery: guidelines and recommendations. , 2013, American family physician.

[21]  J. Cronenwett,et al.  The impact of diabetes on postoperative outcomes following lower-extremity bypass surgery. , 2012, Journal of vascular surgery.

[22]  L. Kraiss,et al.  The Society for Vascular Surgery Vascular Quality Initiative. , 2012, Journal of vascular surgery.

[23]  R. Rosenthal,et al.  Glycemic Control and Infections in Patients with Diabetes Undergoing Noncardiac Surgery , 2011, Annals of surgery.

[24]  I. Shimomura,et al.  The Influence of Glycemic Control on the Prognosis of Japanese Patients Undergoing Percutaneous Transluminal Angioplasty for Critical Limb Ischemia , 2010, Diabetes Care.

[25]  N. Collins,et al.  Multivitamin supplements--magic bullet or waste of money? , 2010, Ostomy/wound management.

[26]  H. Welch,et al.  National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. , 2009, Journal of vascular surgery.

[27]  S. Lipsitz,et al.  Relationship of Perioperative Hyperglycemia and Postoperative Infections in Patients Who Undergo General and Vascular Surgery , 2008, Annals of surgery.

[28]  R. Town,et al.  National health care costs of peripheral arterial disease in the Medicare population , 2008, Vascular medicine.

[29]  J. Bax,et al.  Impaired glucose regulation, elevated glycated haemoglobin and cardiac ischaemic events in vascular surgery patients , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[30]  Marjana Tomic-Canic,et al.  Cellular and molecular basis of wound healing in diabetes. , 2007, The Journal of clinical investigation.

[31]  I. Baumgartner,et al.  Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. , 2007, Journal of vascular surgery.

[32]  G. Avalos,et al.  Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome? , 2006, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[33]  A. Sharrett,et al.  HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study. , 2006, Diabetes care.

[34]  W. Hiatt,et al.  Peripheral arterial disease in patients with diabetes. , 2006, Journal of the American College of Cardiology.

[35]  J. Beckman,et al.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I , 2013, European heart journal.

[36]  G. Eknoyan,et al.  National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.

[37]  David Roth,et al.  A simplified equation to predict glomerular filtration rate from serum creatinine , 2000 .

[38]  A. Aljada,et al.  Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. , 2000, The Journal of clinical endocrinology and metabolism.

[39]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[40]  B. Genetet,et al.  Impaired Leucocyte Functions in Diabetic Patients , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[41]  P. Wilson,et al.  High hemoglobin A1c associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization , 2018, Journal of Vascular Surgery.

[42]  David G Armstrong,et al.  The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). , 2014, Journal of vascular surgery.

[43]  N. Collins,et al.  The Importance of Glycemic Control in Wound Healing , 2010 .

[44]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .